FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 29

Author

Admin 422 posts 0 comments

Whitepaper

FINANCIAL SERVICES IN A CHANGED WORLD

Admin Feb 11, 2025
Globalization and digitization were transforming the way we work even before the global COVID-19 pandemic, but…
Articles

Operational Risks in Banks: Effective Strategies to Create a Secure Framework

Admin Feb 10, 2025
Risk events in the banking sector and financial institutions can trigger huge losses. Risk events can be…
Featured News

New Investment Fuels Qount’s AI-Powered Solutions to Streamline Tax and Accounting…

Admin Feb 7, 2025
Savant Growth, a data-driven private equity firm for capital-efficient B2B SaaS companies, and Qount, a…
Webinar

Trusted Transactions: The Future of Risk-Based Authentication

Admin Feb 6, 2025
Join Finextra Research and Mastercard for an insightful webinar discussing the future of risk-based authentication…
Articles

Fintech Strategy: Driving Innovation in Financial Services

Admin Feb 5, 2025
The fintech industry is transforming financial services with AI, blockchain, and digital payments. A strong…
Articles

Fintech & Payments: Transforming the Financial Landscape

Admin Feb 4, 2025
The financial technology (fintech) sector has become a powerhouse of innovation, fundamentally reshaping how…
Articles

New FinTech Innovations Reshaping the Financial Industry in 2025

Admin Feb 3, 2025
The financial industry is undergoing a significant transformation in 2025, driven by cutting-edge FinTech…
Whitepaper

FinTech Futures media pack, advertising & marketing services

Admin Jan 30, 2025
In today’s fast moving and highly competitive market, it is essential to maintain a competitive edge. FinTech…
Webinar

Webinar | 24 February 2025 | Meeting financial customer demands: efficiency in…

Admin Jan 29, 2025
Date: Monday, 24 February 2025Time: 1:00 PM GMT | 8am EST The financial services industry is under immense…
Featured News

US Consumer Spending Shows First Pandemic Contraction: Survey

Admin Jan 28, 2025
In a recent survey, alarming statistics have emerged, painting a concerning picture for the US economy. For the…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Understanding Credit Card Losses: Causes, Prevention, and Recovery
    • Everything You Should Know About Contactless Payments
    • Embedded banking but not as you know it
    • How Smart Money Management and Digital Trends Are Reshaping Wealth in 2026
    • INVESTMENT GUIDE Investing for your future

    ARTICLE

    Imviva Biotech Presents Data Demonstrating Durable Clinical Responses from Ongoing Phase 1/2 Study of CTA313 in Systemic Lupus Erythematosus at ASGCT 2026
    2026-05-14T15:43:11Z
    100% of patients treated with CTA313 achieved an SRI-4 response, with half achieving remission


    Terumo Neuro Announces Publication of Landmark RAGE Study Results for HydroCoil™ Embolic System Coils for Ruptured Intracranial Aneurysms
    2026-05-14T15:29:00Z
    Largest prospective, core lab–adjudicated trial in North America confirms strong occlusion, low rebleeding, and favorable functional independence


    DentPrime Introduces an “International Complication Protection Program” for Overseas Dental Patients
    2026-05-14T15:00:00Z
    New initiative to increase patient confidence and long-term aftercare support in international dental treatment


    Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026)
    2026-05-14T15:00:00Z
    Company announcement No. 16 / 2026


    ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026
    2026-05-14T14:47:26Z
    MADRID and CAMBRIDGE, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, today reported financial...


    Tessera Therapeutics Showcases New Preclinical Data Advancing In Vivo Program in Sickle Cell Disease and CAR-T Applications at the American Society of Gene and Cell Therapy 29th Annual Meeting
    2026-05-14T14:20:08Z
    SOMERVILLE, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Tessera Therapeutics (“Tessera”), the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, is presenting updates across its...


    Inner Voyage Recovery Center launches virtual intensive outpatient program for Georgia and beyond
    2026-05-14T14:00:00Z
    Woodstock rehab brings structured addiction treatment to patients who can't access in-person treatment — wherever they are.


    Lanier Recovery Center opens its doors in Suwanee, Georgia, bringing comprehensive addiction treatment to the Atlanta region
    2026-05-14T14:00:00Z
    Lanier Recovery Center opens in Suwanee to give Atlanta-area individuals and families a trusted local resource for addiction treatment and mental health care.


    NFL Hall of Famer Brett Favre Reports Significant Parkinson's Medication Reduction as Zhittya Genesis Medicine Marks Four Years of Parkinson’s Research
    2026-05-14T14:00:00Z
    The three-time NFL MVP, Super Bowl XXXI Champion, and former Green Bay Packers quarterback says he has been treated twice with Zhittya's investigational biologic and has "significantly" reduced his dopamine...


    Red Ribbon Recovery Colorado now offers virtual addiction treatment to patients across the United States
    2026-05-14T14:00:00Z
    Addiction and mental health treatment, delivered virtually across the U.S.


    ApolloMD Recognized as One of the Best Places to Work in Healthcare in 2026
    2026-05-14T13:35:31Z
    ATLANTA, May 14, 2026 (GLOBE NEWSWIRE) -- ApolloMD has been selected by Modern Healthcare 2026 Best Places to Work in Healthcare, recognizing healthcare organizations that foster strong workplace culture, support...


    Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer
    2026-05-14T13:27:00Z
    Preliminary results from a preclinical study demonstrated statistically significant increase in MHC-I expression following SIL204 treatment in human pancreatic and non-small cell lung cancer cells harboring a KRAS mutation, supporting...


    TOMI Environmental Solutions, Inc. Announces Second SteraMist Hybrid System Installation Contract with a World-Renowned East Coast Research University
    2026-05-14T13:20:00Z
    FREDERICK, Md., May 14, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announce that we have been awarded the...


    Polaryx Therapeutics Receives GHP Magazine’s Healthcare & Pharmaceuticals Awards
    2026-05-14T13:15:00Z
    Company selected as Best Pediatric Lysosomal Storage Disease Therapeutics and Rare Neurodegenerative Disease Drug Development Excellence Award Winner


    Sonablate Launches SONA FUSION Global Registry to Advance Precision Sound Medicine and Define Future Standards in Focal Therapy
    2026-05-14T13:03:00Z
    First multinational initiative dedicated to long-term HIFU outcomes in prostate cancer and BPH aims to help close the evidence gap in incision-free prostate care


    CJ Biomaterials Launches New Home Compostable all-PHA Extrusion Coating Resin for Paper Food Serviceware
    2026-05-14T13:00:00Z
    WOBURN, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- CJ Biomaterials, Inc., a division of South Korea-based CJ CheilJedang and a primary producer of polyhydroxyalkanoate (PHA) biopolymers, has announced the commercial...


    Syneos Health Expands Strategic AI Partnerships to Advance Commercial Precision Performance
    2026-05-14T13:00:00Z
    MORRISVILLE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Syneos Health® today announced new and expanded strategic partnerships that strengthen its cutting-edge, AI ecosystem. These innovative solutions represent best-in-breed technologies that...


    Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission
    2026-05-14T12:53:00Z
    Completed GMP manufacturing and toxicology milestones supporting planned Q4 2026 IND submission for ulcerative colitis


    Administrative Experience Emerges as Key Pressure Point for Self-Funded Plans, Brighton Health Plan Solutions Survey Finds
    2026-05-14T12:45:00Z
    New report shows employee satisfaction remains high, but trust can break down when administrative friction gets in the way


    Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase
    2026-05-14T12:45:00Z
    Secured strategic financing vehicle for up to $40 million Positive FDA feedback supports single-arm pivotal trial for potential registration of SENTI-202 in initial indication of Relapsed/Refractory Acute Myeloid Leukemia (R/R...


    AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer
    2026-05-14T12:41:00Z
    Positive Data from Named Patient Program and Positive Interim Data from Ongoing Phase 2 Clinical Trial


    Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program
    2026-05-14T12:40:00Z
    Following a Type B meeting with FDA, Senti Bio plans to proceed with a single-arm multi-center registrational trial for SENTI-202, building off the strong Phase 1 clinical results demonstrating deep...


    Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers
    2026-05-14T12:40:00Z
    Terreplenish® leads the way as company responds to worldwide nitrogen shortage


    GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline
    2026-05-14T12:35:00Z
    Phase 2a data show zero cough and 60% lower treatment-related diarrhea than placebo despite higher nintedanib use in the active arm – suggesting GRI-0621 may mitigate nintedanib-related GI-toxicities when used...


    Biogen Completes Acquisition of Apellis Pharmaceuticals
    2026-05-14T12:35:00Z
    CAMBRIDGE, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc. (Nasdaq: APLS). Apellis, a leader in...


    Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment
    2026-05-14T12:32:00Z
    First-of-its-kind partnership expands NeuroStar platform capabilities with advanced visualization technology designed to address evolving provider needs and support more personalized treatment planning


    20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026
    2026-05-14T12:31:00Z
    GAITHERSBURG, Md., May 14, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (“20/20”) (Nasdaq: AIDX), an early market entrant in cutting-edge, AI powered laboratory-based blood tests for the early detection and...


    Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
    2026-05-14T12:30:00Z
    MONTREAL and CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that management...


    Dogwood Therapeutics Announces First Quarter 2026 Financial Results
    2026-05-14T12:30:00Z
    - Halneuron® Phase 2b trial in Chemotherapy Induced Neuropathy on track for top-line results in fall 2026 -


    Biodexa issues letter to Shareholders
    2026-05-14T12:30:00Z
    May 14, 2026

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.